Medpace Holdings Pre-Tax Profit Margin 2014-2024 | MEDP
Medpace Holdings Pre-Tax Profit Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
2024-09-30 | $2.07B | $0.43B | 20.92% |
2024-06-30 | $2.03B | $0.40B | 19.57% |
2024-03-31 | $1.96B | $0.36B | 18.50% |
2023-12-31 | $1.89B | $0.34B | 17.82% |
2023-09-30 | $1.78B | $0.32B | 17.91% |
2023-06-30 | $1.67B | $0.32B | 19.01% |
2023-03-31 | $1.56B | $0.30B | 19.45% |
2022-12-31 | $1.46B | $0.28B | 19.38% |
2022-09-30 | $1.38B | $0.27B | 19.27% |
2022-06-30 | $1.29B | $0.24B | 18.49% |
2022-03-31 | $1.21B | $0.22B | 18.04% |
2021-12-31 | $1.14B | $0.20B | 17.76% |
2021-09-30 | $1.09B | $0.20B | 18.46% |
2021-06-30 | $1.03B | $0.19B | 18.87% |
2021-03-31 | $0.96B | $0.18B | 18.95% |
2020-12-31 | $0.93B | $0.17B | 18.14% |
2020-09-30 | $0.90B | $0.15B | 16.63% |
2020-06-30 | $0.88B | $0.13B | 14.85% |
2020-03-31 | $0.89B | $0.14B | 15.15% |
2019-12-31 | $0.86B | $0.12B | 14.40% |
2019-09-30 | $0.82B | $0.12B | 14.22% |
2019-06-30 | $0.79B | $0.11B | 14.38% |
2019-03-31 | $0.74B | $0.10B | 13.61% |
2018-12-31 | $0.70B | $0.09B | 13.35% |
2018-09-30 | $0.63B | $0.08B | 12.64% |
2018-06-30 | $0.56B | $0.07B | 12.39% |
2018-03-31 | $0.49B | $0.06B | 12.37% |
2017-12-31 | $0.44B | $0.06B | 13.04% |
2017-09-30 | $0.43B | $0.04B | 9.95% |
2017-06-30 | $0.43B | $0.04B | 8.39% |
2017-03-31 | $0.43B | $0.03B | 6.99% |
2016-12-31 | $0.42B | $0.02B | 5.21% |
2016-06-30 | $0.30B | $0.02B | 5.03% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $9.789B | $1.886B |
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $91.424B | 11.34 |
Cencora (COR) | United States | $47.484B | 17.51 |
DiDi Global (DIDIY) | China | $23.330B | 0.00 |
Natera (NTRA) | United States | $21.401B | 0.00 |
ICON (ICLR) | Ireland | $16.136B | 14.37 |
Viatris (VTRS) | United States | $15.576B | 4.80 |
Avantor (AVTR) | United States | $13.422B | 20.12 |
Revvity (RVTY) | United States | $13.376B | 23.24 |
CochLear (CHEOY) | Australia | $12.844B | 0.00 |
BioMerieux (BMXMF) | France | $12.666B | 0.00 |
Solventum (SOLV) | United States | $11.583B | 0.00 |
Doximity (DOCS) | United States | $9.620B | 56.63 |
Charles River Laboratories (CRL) | United States | $9.516B | 18.39 |
HealthEquity (HQY) | United States | $8.966B | 48.66 |
Sonic Healthcare (SKHHY) | Australia | $8.758B | 0.00 |
Bausch + Lomb (BLCO) | Canada | $6.885B | 32.05 |
Life Times (LTH) | United States | $5.085B | 33.66 |
Sotera Health (SHC) | United States | $3.855B | 20.62 |
Organon (OGN) | United States | $3.757B | 3.79 |
BrightSpring Health Services (BTSG) | United States | $3.247B | 69.07 |
Surgery Partners (SGRY) | United States | $2.892B | 32.97 |
PACS (PACS) | United States | $2.606B | 0.00 |
Concentras Parent (CON) | United States | $2.581B | 0.00 |
Ardent Health Partners (ARDT) | United States | $2.375B | 0.00 |
Premier (PINC) | United States | $2.143B | 11.15 |
Alignment Healthcare (ALHC) | United States | $2.126B | 0.00 |
Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
GeneDx Holdings (WGS) | United States | $1.952B | 0.00 |
GoodRx Holdings (GDRX) | United States | $1.616B | 42.40 |
Teladoc Health (TDOC) | United States | $1.537B | 0.00 |
Pediatrix Medical (MD) | United States | $1.255B | 12.28 |
CareDx (CDNA) | United States | $1.183B | 0.00 |
Progyny (PGNY) | United States | $1.164B | 23.57 |
Establishment Labs Holdings (ESTA) | $1.050B | 0.00 | |
AMN Healthcare Services Inc (AMN) | United States | $0.954B | 6.46 |
QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
Embecta (EMBC) | United States | $0.778B | 5.18 |
SBC Medicals (SBC) | United States | $0.677B | 0.00 |
Agilon Health (AGL) | United States | $0.655B | 0.00 |
InnovAge Holding (INNV) | United States | $0.647B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.536B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.425B | 0.00 |
DocGo (DCGO) | United States | $0.410B | 15.46 |
Enhabit (EHAB) | United States | $0.366B | 31.61 |
COMPASS Pathways (CMPS) | United Kingdom | $0.326B | 0.00 |
LifeMD (LFMD) | United States | $0.241B | 0.00 |
ModivCare (MODV) | United States | $0.223B | 12.09 |
Sera Prognostics (SERA) | United States | $0.209B | 0.00 |
Beauty Health (SKIN) | United States | $0.200B | 0.00 |
Biodesix (BDSX) | United States | $0.180B | 0.00 |
Nutex Health (NUTX) | United States | $0.156B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.100B | 0.00 |
So-Young (SY) | China | $0.092B | 22.25 |
MultiPlan (MPLN) | United States | $0.084B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.054B | 0.00 |
OncoCyte (OCX) | United States | $0.043B | 0.00 |
NeueHealth (NEUE) | United States | $0.041B | 1.08 |
Co-Diagnostics (CODX) | United States | $0.034B | 0.00 |
Pheton Holdings (PTHL) | China | $0.030B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.028B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.020B | 0.00 |
Oncology Institute (TOI) | United States | $0.014B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
XWELL (XWEL) | United States | $0.008B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
KindlyMD (KDLY) | United States | $0.005B | 0.00 |
ISpecimen (ISPC) | United States | $0.004B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |
Cano Health (CANOQ) | United States | $0.001B | 0.00 |